alnylam

Alnylam Receives Approval for GIVLAARI™ (givosiran) by the U.S. Food and Drug Administration (FDA)

Alnylam Receives Approval for GIVLAARI™ (givosiran) by the U.S. Food and Drug Administration (FDA) …………… With a Herculean effort by Alnylam chemists, biologists, clinical collaborators and patients, the first ever GalNAc-siRNA conjugate, Givosiran (Givlaari), passed the finish line on Wednesday and was approved by the US FDA (1,2). Givosiran selectively knocksdown the AminoLevulinic Acid Synthase…